This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Molecular Analysis Of Bladder Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Linda Topjian, Lahey Clinic
ClinicalTrials.gov Identifier:
NCT00871754
First received: March 26, 2009
Last updated: March 7, 2017
Last verified: March 2017
  Purpose
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.

Condition
Bladder Cancer Bladder Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Analysis Of Bladder Cancer

Resource links provided by NLM:


Further study details as provided by Linda Topjian, Lahey Clinic:

Biospecimen Retention:   Samples With DNA
Blood

Estimated Enrollment: 5000
Study Start Date: April 1988
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patient's undergoing removal of a malignant bladder tumor
Criteria

Inclusion Criteria:

  • Bladder cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00871754

Locations
United States, Massachusetts
Lahey Clinic
Burlington, Massachusetts, United States, 01805
Sponsors and Collaborators
Lahey Clinic
Investigators
Principal Investigator: Kim Reiger-Christ, PhD Lahey Clinic
  More Information

Responsible Party: Linda Topjian, study coordinator, Lahey Clinic
ClinicalTrials.gov Identifier: NCT00871754     History of Changes
Other Study ID Numbers: 88-009A
Study First Received: March 26, 2009
Last Updated: March 7, 2017

Keywords provided by Linda Topjian, Lahey Clinic:
Bladder Cancer
Cancer, bladder
Urinary Bladder Cancer

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on August 18, 2017